LQDA Stock Summary and Trading Ideas (Liquidia | NASDAQ:LQDA)

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Liquidia trades on the NASDAQ stock market under the symbol LQDA.

As of April 24, 2024, LQDA stock price declined to $12.62 with 382,812 million shares trading.

LQDA has a beta of 0.76, meaning it tends to be less sensitive to market movements. LQDA has a correlation of 0.02 to the broad based SPY ETF.

LQDA has a market cap of $959.47 million. This is considered a Small Cap stock.

Last quarter Liquidia reported $5 million in Revenue and -$.42 earnings per share. This fell short of revenue expectation by $-199,000 and missed earnings estimates by -$.19.

In the last 3 years, LQDA stock traded as high as $16.99 and as low as $2.25.

The top ETF exchange traded funds that LQDA belongs to (by Net Assets): VTI, IWM, VXF, IWO, DWAS.

LQDA has outperformed the market in the last year with a return of +81.8%, while the SPY ETF gained +23.8%. However, in the most recent history, LQDA shares have underperformed the stock market with its stock returning +3.0% in the last 3 month period and -15.6% for the last 2 week period, while SPY has returned +4.2% and -3.1%, respectively.

LQDA support price is $12.50 and resistance is $13.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LQDA stock will trade within this expected range on the day.